Mark C. Schneyer

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark C. Schneyer:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC EVP, CHIEF FINANCIAL OFFICER Common Stock 53,338 $1,263,614 $23.69 18 Nov 2025 Direct
ACADIA PHARMACEUTICALS INC EVP, CHIEF FINANCIAL OFFICER Restricted Stock Units 0 $78,190 $14.82 17 Nov 2025 Direct
ACADIA PHARMACEUTICALS INC EVP, CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 110,761 24 Mar 2025 Direct

Insider Reports Filed by Mark C. Schneyer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 17 Nov 2025 5 -$243,114 4 EVP, CHIEF FINANCIAL OFFICER 19 Nov 2025, 18:00
ACAD ACADIA PHARMACEUTICALS INC 12 Sep 2025 2 -$82,728 4 EVP, CHIEF FINANCIAL OFFICER 16 Sep 2025, 18:00
ACAD ACADIA PHARMACEUTICALS INC 18 Aug 2025 1 -$554,024 4 EVP, CHIEF FINANCIAL OFFICER 19 Aug 2025, 18:00
ACAD ACADIA PHARMACEUTICALS INC 16 May 2025 1 -$50,000 4 EVP, CHIEF FINANCIAL OFFICER 19 May 2025, 20:50
ACAD ACADIA PHARMACEUTICALS INC 01 May 2025 3 -$51,071 4 EVP, CHIEF FINANCIAL OFFICER 02 May 2025, 19:59
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2025 3 -$40,133 4 EVP, CHIEF FINANCIAL OFFICER 08 Apr 2025, 19:40
ACAD ACADIA PHARMACEUTICALS INC 24 Mar 2025 5 -$54,066 4 EVP, CHIEF FINANCIAL OFFICER 26 Mar 2025, 20:06
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2025 3 -$15,429 4 EVP, CHIEF FINANCIAL OFFICER 25 Feb 2025, 18:46
ACAD ACADIA PHARMACEUTICALS INC 17 Nov 2024 5 -$172,454 4 EVP, CHIEF FINANCIAL OFFICER 19 Nov 2024, 20:40
ACAD ACADIA PHARMACEUTICALS INC 16 Aug 2024 3 -$148,720 4 EVP, CHIEF FINANCIAL OFFICER 20 Aug 2024, 18:46
ACAD ACADIA PHARMACEUTICALS INC 08 Jun 2024 3 -$14,420 4 EVP, CHIEF FINANCIAL OFFICER 11 Jun 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 01 May 2024 3 -$59,341 4 EVP, CHIEF FINANCIAL OFFICER 03 May 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2024 3 -$48,535 4 EVP, CHIEF FINANCIAL OFFICER 09 Apr 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 25 Mar 2024 4 -$97,269 4 EVP, CHIEF FINANCIAL OFFICER 27 Mar 2024, 19:57
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2024 3 -$19,045 4 EVP, CHIEF FINANCIAL OFFICER 27 Feb 2024, 18:13
ACAD ACADIA PHARMACEUTICALS INC 17 Nov 2023 5 -$115,645 4 EVP, Chief Financial Officer 21 Nov 2023, 18:00
ACAD ACADIA PHARMACEUTICALS INC 21 Aug 2023 1 -$289,970 4 EVP, Chief Financial Officer 23 Aug 2023, 20:31
ACAD ACADIA PHARMACEUTICALS INC 08 Jun 2023 3 -$24,369 4 EVP, Chief Financial Officer 12 Jun 2023, 20:48
ACAD ACADIA PHARMACEUTICALS INC 17 May 2023 5 -$344,475 4 EVP, Chief Financial Officer 19 May 2023, 18:48
ACAD ACADIA PHARMACEUTICALS INC 01 May 2023 2 $0 4 EVP, Chief Financial Officer 03 May 2023, 21:15
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2023 3 -$34,795 4 EVP, Chief Financial Officer 07 Apr 2023, 20:37
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2023 3 -$10,836 4 EVP, Chief Financial Officer 27 Feb 2023, 20:00
ACAD ACADIA PHARMACEUTICALS INC 08 Jun 2022 3 -$11,695 4 EVP, Chief Financial Officer 10 Jun 2022, 20:51
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2022 2 $0 4 EVP, Chief Financial Officer 07 Apr 2022, 18:49
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2022 3 -$13,161 4 Chief Financial Officer 25 Feb 2022, 16:43
ACAD ACADIA PHARMACEUTICALS INC 09 Dec 2021 0 $0 3 Chief Financial Officer 20 Dec 2021, 17:00